Molina Healthcare, Inc.

MOH · Healthcare · · USD

234.96 USD

+0.00 (1.24%)

● Updated 2026-07-10 19:08 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Long-term (Investment)

/ 100

Technical 80

Trend & RS 96

Momentum 91

Fundamental 83

Macro 71

Liquidity 31

Component	Score	Weight
Technical	80.0	10%
Trend & RS	96.4	10%
Momentum	91.2	5%
Fundamental	83.3	40%
Macro	71.2	15%
Liquidity	30.9	20%

Trade Setup

Entry	234.11
Stop Loss	216.47 (7.5%)
Target 1 (1:1)	251.75 (+7.5%)
Target 2 (2:1)	269.39 (+15.1%)

ATR(14)	8.82 (3.8%)
Risk per Share	17.64
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	47.6	-0.10
Momentum	91.2	+1.65
Quality	27.4	-0.91
Composite	55.4

Quality Scores

Piotroski F-Score 6 /9 — Average

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✗ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 5.46 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Fair Value

Metric	Stock	Sector	vs Peers
P/E Ratio	62.8	22.0	+186% above
P/B Ratio	3.0	4.0	Below

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

46.17

Market Price

234.96

Upside

-80.4%

Margin of Safety	-408.9%
Stage 1 PV (5yr FCF)	641,507,686
Terminal Value PV	1,763,917,184
Total Enterprise Value	2,405,424,870

Assumptions

Base FCF	155,883,200
Growth Rate (5yr)	2.0%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

47.17%

Full Kelly

23.58%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 72/100. Estimated win rate 62%, avg win 9.3%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

72.03

RSI(14)

11.7968

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↑ RISING (+50.4% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	Near 3-month high 9d since high
Sector Outperformance	+58.2% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	72.03	OVERBOUGHT
Macd	11.7968	BULLISH
Ma Cross	198.94 / 171.12	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.17x	LOW

Key Levels

Level	Price
52-Week High	243.50
Bollinger Upper	248.45
SMA(200)	171.12
SMA(50)	198.94
SMA(20)	215.3
Current Price	234.96
Bollinger Lower	182.16
52-Week Low	121.06
ATR(14)	8.82

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

DISTRIBUTION A Confidence

50%

Buying Climax

Acc: 0.0 | Dist: 2.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	0.8x	Normal bar — no special VSA pattern
2026-07-07	Normal	0.92x	Normal bar — no special VSA pattern
2026-07-08	Normal	1.02x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.67x	Normal bar — no special VSA pattern
2026-07-10	Normal	0.17x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	232.75	Above Kijun
Kijun-sen (26)	211.89	Base line
Senkou A	222.32	Leading span A
Senkou B	208.11	Leading span B
Cloud	208.11 – 222.32	Bullish (Green)
Price vs Cloud	234.11	Above Cloud
Chikou Span	184.82	Bullish
Alignment Score	4/4	BULLISH